References

  1. Lai MW, Klein-Schwartz W, Rodgers GC, Abrams JY, Haber DA, Bronstein AC, Wruk KM. 2005 Annual Report of the American Association of Poison Control Centers’ National Poisoning and Exposure Database. Clinical Toxicology 2006; 44:803-932.
  2. Litovitz T. The alcohols: Ethanol, methanol, isopropanol, ethylene glycol. Pediatr Clin North Am 1986; 33:311-323.
  3. Jacobsen D, McMartin KE. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol 1986; 1:309-334.
  4. Barceloux DG, Krenzelok EP, Olson K, Watson W. American Academy of Clinical Toxicology Practice guidelines on the treatment of ethylene glycol poisoning. J Toxicol Clin Toxicol 1999; 37:537-560.
  5. Brent J, McMartin K, Phillips S, Aaron C, Kulig K, Methylpyrazole for Toxic Alcohols Study Group. Fomepizole for the treatment of methanol poisoning. N Engl J Med 2001; 344:424-429.
  6. Jacobsen D, McMartin KE. Antidotes for methanol and ethylene glycol poisoning.J Toxicol Clin Toxicol 1997; 35:127-143.
  7. Hovda KE, Hunderi OH, Tafjord AB, Dunlop O, Rudberg N, Jacobsen D. Methanol outbreak in Norway 2002-2004: Epidemiology, clinical features and prognostic signs. J Intern Med 2005; 258:181-90.
  8. LoVecchio F, Sawyers B, Thole D, Beuler MC, Winchell J, Curry SC. Outcomes following abuse of methanol-containing carburetor cleaners. Hum Exp Toxicol 2004; 23:473-475.
  9. Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA. American Academy of Clinical Toxicology Practice guidelines on the treatment of methanol poisoning.J Toxicol Clin Toxicol 2002; 40:415-446.
  10. Suit PF, Estes ML. Methanol intoxication: Clinical features and differential diagnosis. Clevel Clin J Med 1990; 57:464-471.
  11. Jacobsen D, Bredesen JE, Eide I, Ostborg J. Anion and osmolal gaps in the diagnosis of methanol and ethylene glycol poisoning. Acta Med Scand 1982; 212:17-20.
  12. Antizol® (fomepizole) Injection Package Insert
  13. Mégarbane B, Borron SW, Baud F. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med 2005; 31:189-195.
  14. Marraffa JM, et al. Cost-effectiveness of fomepizole vs. ethanol in the management of acute ethylene glycol exposure. J Toxicol Clin Toxicol 2005; 43:691.
  15. Pietruszko R. Human liver alcohol dehydrogenase—inhibition of methanol activity by pyrazole, 4-methylpyrazole, 4-hydroxymethylpyrazole and 4-carboxypyrazole. Biochem Pharmacol 1975; 24:1603-1607.
  16. Brent J, et al. Fomepizole for the treatment of ethylene glycol poisoning. N Engl J Med 1999; 3:832-838.
  17. Borron SW, Mégarbane B, Baud FJ. Fomepizole in treatment of uncomplicated ethylene glycol poisoning. Lancet 1999; 354:831.
  18. Sivilotti MLA, Burns MJ, McMartin KE, Brent J. Toxicokinetics of ethylene glycol during fomepizole therapy: Implications for management. Ann Emerg Med 2000; 36:114-125.
  19. Mégarbane B, Borron SW, Trout H, Hanston P, Jaeger A, Krencker E, Bismuth C, Baud F. Treatment of acute methanol poisoning with fomepizole. Intensive Care Med 2001; 7:1370-1378.
  20. Caravati EM, et al. Treatment of severe pediatric ethylene glycol intoxication without hemodialysis. J Toxicol Clin Toxicol 2004; 42:255-259.
  21. Lushine KA, Harris CR, Holger JS. Methanol ingestion: Prevention of toxic sequelae after massive ingestion. J Emerg Med 2003; 24:433-436.
  22. Brent, J. Current management of ethylene glycol poisoning. Drugs 2001; 61:979-988.
  23. Shiew CM, Dargan PI, Greene SL, Jones AL. National Poisons Information Service, London, United Kingdom. An Economic Analysis: Is Fomepizole Really More Expensive Than Ethanol for the Treatment of Ethylene Glycol Poisoning? J Toxicol Clin Toxicol 2005; 43:690.